Lifeward restores Nasdaq audit committee compliance

Lifeward Ltd. reported that it has restored compliance with a key Nasdaq corporate governance rule.

Rhea-AI Filing Summary

Lifeward Ltd. reported that it has restored compliance with a key Nasdaq corporate governance rule. The company previously fell out of compliance with Nasdaq Listing Rule 5605(c)(2)(A) after director Hadar Levy resigned from the Board and its Audit Committee, leaving the committee below the required three members.

Nasdaq staff sent written notice on March 30, 2026, acknowledging the appointments of Moshe Rozenbaum, William Mark Sigsbee and Yehuda Reznick to the Audit Committee and confirming that Lifeward now meets the three-member requirement. Nasdaq stated the company is again in compliance with the rule and that the matter is closed.

Insights

Corporate governance analyst

Lifeward resolves Nasdaq audit committee deficiency and closes the issue.

Lifeward Ltd. had been out of compliance with Nasdaq Listing Rule 5605(c)(2)(A) after an audit committee member resigned, leaving fewer than the required three members. Nasdaq provides a cure period for companies to fix such governance gaps.

On March 30, 2026, Nasdaq staff confirmed that appointing Moshe Rozenbaum, William Mark Sigsbee and Yehuda Reznick to the Audit Committee restores compliance and closes the matter. This removes a listing-related overhang, but it is primarily an administrative governance step rather than a change to the company’s operating performance.

8-K Event Classification

Item 8.01 — Other Events

1 item

Item 8.01 Other Events Other

Voluntary disclosure of events the company deems important to shareholders but not covered by other items.

Key Figures

Nasdaq rule cited: Listing Rule 5605(c)(2)(A) Cure period deadline (later date): February 24, 2027 Alternate cure deadline: August 24, 2026 +2 more

5 metrics

Nasdaq rule cited Listing Rule 5605(c)(2)(A) Requires at least three audit committee members

Cure period deadline (later date) February 24, 2027 Latest date Nasdaq allowed to regain audit committee compliance

Alternate cure deadline August 24, 2026 Applies if next annual meeting occurs before that date

Nasdaq confirmation date March 30, 2026 Date staff confirmed Lifeward’s renewed compliance

Audit Committee members 3 members Moshe Rozenbaum, William Mark Sigsbee, Yehuda Reznick appointed

Key Terms

Nasdaq Listing Rule 5605(c)(2)(A), Audit Committee, emerging growth company, Nasdaq Listing Qualifications Department

4 terms

Nasdaq Listing Rule 5605(c)(2)(A) regulatory

"no longer complied with Nasdaq Listing Rule 5605(c)(2)(A), which requires listed companies to have an audit committee of at least three members"

Audit Committee financial

"appointment of Messrs. Moshe Rozenbaum, William Mark Sigsbee and Yehuda Reznick to the Audit Committee"

A company's audit committee is a small group of board members who act like independent inspectors for the firm's finances, overseeing how financial reports are prepared, monitoring internal controls, and managing the relationship with external auditors. Investors care because a strong audit committee reduces the risk of accounting errors, fraud, or misleading statements, making financial statements more trustworthy and helping protect shareholder value.

emerging growth company regulatory

"Emerging growth company"

An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.

Nasdaq Listing Qualifications Department regulatory

"received written notice from the Nasdaq Listing Qualifications Department of the Nasdaq Stock Market LLC"

The Nasdaq Listing Qualifications Department is the team at the Nasdaq stock market that monitors whether listed companies meet the exchange’s rules for things like minimum share price, market value, timely financial reporting and governance. Its role matters to investors because its notices, warnings or enforcement actions—ranging from reminders to suspension or delisting—can sharply affect a stock’s trading, liquidity and perceived risk; think of it as the referee enforcing the marketplace’s entry and conduct rules.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What Nasdaq compliance issue did Lifeward Ltd. (LFWD) face?

Lifeward temporarily failed to meet Nasdaq Listing Rule 5605(c)(2)(A) after director Hadar Levy resigned, leaving its Audit Committee with fewer than three members. Nasdaq rules require at least three audit committee members for continued listing eligibility.

How did Lifeward Ltd. (LFWD) regain compliance with Nasdaq rules?

Lifeward regained compliance by appointing Moshe Rozenbaum, William Mark Sigsbee and Yehuda Reznick to its Audit Committee. Nasdaq staff then sent written notice on March 30, 2026, confirming the committee now meets the three-member requirement and closing the compliance matter.

What does Nasdaq Listing Rule 5605(c)(2)(A) require for Lifeward (LFWD)?

Nasdaq Listing Rule 5605(c)(2)(A) requires listed companies like Lifeward to maintain an Audit Committee of at least three members. Falling below this threshold triggers a deficiency notice and cure period until the company restores the minimum committee size.

Who are the new Audit Committee members at Lifeward Ltd. (LFWD)?

The Audit Committee now includes Messrs. Moshe Rozenbaum, William Mark Sigsbee and Yehuda Reznick. Their appointments brought the committee back to at least three members, satisfying Nasdaq’s audit committee composition requirement under Listing Rule 5605(c)(2)(A).

Is the Nasdaq compliance matter for Lifeward Ltd. (LFWD) now resolved?

Yes. Nasdaq staff sent written notice on March 30, 2026, stating Lifeward is now in compliance with Listing Rule 5605(c)(2)(A) and that the matter is closed. This means no ongoing Nasdaq deficiency related to the Audit Committee composition is outstanding.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/31/2026 - 08:30 AM Learn about SEC filing dates

false0001607962L300-00000002 Cabot Rd., Hudson, MAFloor 6Yokneam Ilit+508.251.11544.959.0123Ordinary Shares, par value NIS 0.25NASDAQ00016079622026-03-302026-03-30

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 30, 2026

Lifeward Ltd.

(Exact name of registrant as specified in its charter)

Israel		001-36612		Not applicable
(State or other jurisdiction of  incorporation or organization)		(Commission File Number)		(IRS Employer Identification No.)

2 Cabot Rd., Hudson, MA		01749
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: +508.251.1154

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol		Name of each exchange on which registered
Ordinary Shares, no par value		LFWD		Nasdaq Capital Market

☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 8.01          Other Events.

As previously disclosed, Lifeward Ltd. (the “Company”) received written notice (the “Notice”) from the Nasdaq Listing Qualifications Department of the Nasdaq Stock Market LLC (the “Staff”) stating that the Company, as a result of the resignation of Hadar Levy from the Company’s Board of Directors (the “Board”) and its Audit Committee, no longer complied with Nasdaq Listing Rule 5605(c)(2)(A), which requires listed companies to have an audit committee of at least three members. The Notice also acknowledged that the Nasdaq Listing Rules provide a cure period in order for the Company to regain compliance until the earlier of the Company’s next annual meeting of shareholders or February 24, 2027; provided, however, that if the Company’s next annual meeting of shareholders is held before August 24, 2026, then the Company must evidence compliance no later than August 24, 2026.

On March 30, 2026, the Company received written notice from the Staff acknowledging the appointment of Messrs. Moshe Rozenbaum, William Mark Sigsbee and Yehuda Reznick to the Audit Committee and stated that the Company is now in compliance with Nasdaq Listing Rule 5605(c)(2)(A) and the matter is now closed

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Lifeward Ltd.
Dated: March 31, 2026	By:	/s/ Almog Adar
	Name:	Almog Adar
	Title:	Chief Financial Officer

Filing Exhibits & Attachments

3 documents

Other Documents

• EX-101 XBRL TAXONOMY EXTENSION SCHEMA 3.8 KB
• EX-101 XBRL TAXONOMY EXTENSION LABEL LINKBASE 21.5 KB
• EX-101 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE 15.7 KB